Zuga Matt
Insider CIK 1790214 · TELA Director · ABOS Chief Financial Officer · AZYO Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-01-22 | 2026-01-23 | 1,687 | $1.86 | $3.1K | 304,924 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-01-21 | 2026-01-23 | 2,473 | $1.81 | $4.5K | 306,611 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2026-01-16 | 2026-01-21 | 148,700 | — | $0 | 148,700 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award | 2026-01-16 | 2026-01-21 | 99,133 | — | $0 | 309,084 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-01-08 | 2026-01-12 | 6,888 | $1.82 | $12.5K | 209,951 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-01-07 | 2026-01-07 | 1,700 | $1.99 | $3.4K | 216,839 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-01-07 | 2026-01-07 | 4,105 | $2.00 | $8.2K | 218,539 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-01-06 | 2026-01-07 | 5,100 | $1.97 | $10.0K | 222,644 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2026-01-05 | 2026-01-07 | 4,000 | $1.96 | $7.8K | 227,744 | SEC↗ |
| ELUT ELUTIA INC. | A Award deriv | 2025-05-29 | 2025-06-02 | 60,339 | — | $0 | 60,339 | SEC↗ |
| ELUT ELUTIA INC. | P Buy | 2025-02-03 | 2025-03-13 | 420,000 | $2.50 | $1.05M | 9,520,232 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2025-01-23 | 2025-01-23 | 28,902 | $1.72 | $49.7K | 231,744 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2025-01-21 | 2025-01-23 | 4,364 | $1.60 | $7.0K | 260,646 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2025-01-06 | 2025-01-07 | 100,300 | — | $0 | 100,300 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award | 2025-01-06 | 2025-01-07 | 66,800 | — | $0 | 265,010 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2025-01-03 | 2025-01-07 | 13,235 | $1.84 | $24.4K | 198,210 | SEC↗ |
| ELUT ELUTIA INC. | X Exercise deriv | 2024-07-30 | 2024-08-01 | 2,101,577 | — | $0 | 0 | SEC↗ |
| ELUT ELUTIA INC. | X Exercise | 2024-07-30 | 2024-08-01 | 2,101,577 | $1.43 | $3.01M | 9,100,232 | SEC↗ |
| ELUT ELUTIA INC. | A Award deriv | 2024-06-06 | 2024-06-10 | 31,835 | — | $0 | 31,835 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | S Sale | 2024-01-18 | 2024-01-19 | 4,242 | $3.71 | $15.7K | 211,445 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2024-01-02 | 2024-01-04 | 159,000 | — | $0 | 159,000 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award | 2024-01-02 | 2024-01-04 | 106,000 | — | $0 | 215,687 | SEC↗ |
| ELUT ELUTIA INC. | J Other deriv | 2023-12-28 | 2024-01-08 | 2,154,116 | — | $0 | 2,101,577 | SEC↗ |
| ELUT ELUTIA INC. | J Other | 2023-12-28 | 2024-01-08 | 1,436,077 | — | $0 | 6,998,655 | SEC↗ |
| AZYO AZIYO BIOLOGICS, INC. | A Award deriv | 2023-06-08 | 2023-06-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AZYO AZIYO BIOLOGICS, INC. | A Award deriv | 2023-06-08 | 2023-06-12 | 37,500 | — | $0 | 37,500 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2023-01-17 | 2023-01-18 | 150,800 | — | $0 | 150,800 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award | 2023-01-17 | 2023-01-18 | 33,500 | — | $0 | 109,687 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | M Exercise deriv | 2022-12-29 | 2023-01-03 | 50,000 | — | $0 | 401,369 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | M Exercise | 2022-12-29 | 2023-01-03 | 50,000 | $1.19 | $59.5K | 76,187 | SEC↗ |
| AZYO AZIYO BIOLOGICS, INC. | A Award deriv | 2022-12-22 | 2022-12-27 | 17,533 | — | $0 | 17,533 | SEC↗ |
| AZYO AZIYO BIOLOGICS, INC. | P Buy | 2022-12-05 | 2022-12-07 | 735,000 | $4.75 | $3.49M | 5,597,604 | SEC↗ |
| AZYO AZIYO BIOLOGICS, INC. | A Award deriv | 2022-06-07 | 2022-06-09 | 22,090 | — | $0 | 22,090 | SEC↗ |
| AZYO AZIYO BIOLOGICS, INC. | A Award deriv | 2022-06-07 | 2022-06-09 | 22,090 | — | $0 | 22,090 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2022-01-19 | 2022-01-21 | 150,000 | — | $0 | 150,000 | SEC↗ |
| AZYO AZIYO BIOLOGICS, INC. | P Buy | 2021-12-08 | 2021-12-10 | 353,773 | $4.24 | $1.50M | 4,862,604 | SEC↗ |
| AZYO AZIYO BIOLOGICS, INC. | P Buy | 2021-12-08 | 2021-12-10 | 58,962 | $4.24 | $250.0K | 90,807 | SEC↗ |
| ELUT ELUTIA INC. | P Buy deriv | 2021-09-21 | 2023-10-05 | 4,255,693 | — | $0 | 4,255,693 | SEC↗ |
| ELUT ELUTIA INC. | P Buy | 2021-09-21 | 2023-10-05 | 2,837,128 | — | $0 | 8,434,732 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | C Conversion deriv | 2021-07-06 | 2021-07-08 | 10,528 | — | $0 | 10,528 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | C Conversion deriv | 2021-07-06 | 2021-07-08 | 15,659 | — | $0 | 15,659 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | C Conversion | 2021-07-06 | 2021-07-08 | 26,187 | — | $0 | 26,187 | SEC↗ |
| AZYO AZIYO BIOLOGICS, INC. | A Award deriv | 2021-06-07 | 2021-06-09 | 14,082 | — | $0 | 14,082 | SEC↗ |
| AZYO AZIYO BIOLOGICS, INC. | A Award deriv | 2021-06-07 | 2021-06-09 | 14,082 | — | $0 | 14,082 | SEC↗ |
| AZYO AZIYO BIOLOGICS, INC. | C Conversion deriv | 2020-10-13 | 2020-10-13 | 31,133,977 | — | $0 | 0 | SEC↗ |
| AZYO AZIYO BIOLOGICS, INC. | X Exercise deriv | 2020-10-13 | 2020-10-13 | 7,655 | — | $0 | 0 | SEC↗ |
| AZYO AZIYO BIOLOGICS, INC. | C Conversion | 2020-10-13 | 2020-10-13 | 4,062,451 | — | $0 | 4,062,451 | SEC↗ |
| AZYO AZIYO BIOLOGICS, INC. | F Tax w/h | 2020-10-13 | 2020-10-13 | 2,451 | $5.44 | $13.3K | 4,067,655 | SEC↗ |
| AZYO AZIYO BIOLOGICS, INC. | P Buy | 2020-10-13 | 2020-10-13 | 441,176 | $17.00 | $7.50M | 4,508,831 | SEC↗ |
| AZYO AZIYO BIOLOGICS, INC. | X Exercise | 2020-10-13 | 2020-10-13 | 7,655 | $5.44 | $41.6K | 4,070,106 | SEC↗ |
| TELA TELA Bio, Inc. | C Conversion deriv | 2019-11-13 | 2019-11-13 | 493,357 | — | $0 | 0 | SEC↗ |
| TELA TELA Bio, Inc. | C Conversion deriv | 2019-11-13 | 2019-11-13 | 6,643 | — | $0 | 0 | SEC↗ |
| TELA TELA Bio, Inc. | C Conversion deriv | 2019-11-13 | 2019-11-13 | 5,377,928 | — | $0 | 0 | SEC↗ |
| TELA TELA Bio, Inc. | C Conversion deriv | 2019-11-13 | 2019-11-13 | 72,417 | — | $0 | 0 | SEC↗ |
| TELA TELA Bio, Inc. | C Conversion deriv | 2019-11-13 | 2019-11-13 | 123,653 | — | $0 | 0 | SEC↗ |
| TELA TELA Bio, Inc. | C Conversion deriv | 2019-11-13 | 2019-11-13 | 123,653 | — | $0 | 123,653 | SEC↗ |
| TELA TELA Bio, Inc. | C Conversion deriv | 2019-11-13 | 2019-11-13 | 1,665 | — | $0 | 0 | SEC↗ |
| TELA TELA Bio, Inc. | C Conversion deriv | 2019-11-13 | 2019-11-13 | 1,665 | — | $0 | 1,665 | SEC↗ |
| TELA TELA Bio, Inc. | C Conversion | 2019-11-13 | 2019-11-13 | 269 | — | $0 | 12,944 | SEC↗ |
| TELA TELA Bio, Inc. | C Conversion | 2019-11-13 | 2019-11-13 | 19,982 | — | $0 | 280,790 | SEC↗ |
| TELA TELA Bio, Inc. | C Conversion | 2019-11-13 | 2019-11-13 | 2,931 | — | $0 | 15,875 | SEC↗ |
| TELA TELA Bio, Inc. | C Conversion | 2019-11-13 | 2019-11-13 | 217,816 | — | $0 | 498,606 | SEC↗ |
| TELA TELA Bio, Inc. | P Buy | 2019-11-08 | 2019-11-13 | 75,901 | $13.00 | $986.7K | 260,808 | SEC↗ |
| TELA TELA Bio, Inc. | P Buy | 2019-11-08 | 2019-11-13 | 10,220 | $13.00 | $132.9K | 12,675 | SEC↗ |